Post Award Notice -21 March 2024.pdf
PDF 65 KB Posted
- Attached to
- Office of Biomedical Advanced Research and Development Authority Broad Agency Announcement (BAA)
- Solicitation number
- 75A50124C00003
About this file
This document is a Post-Award Notice for Contract Number 75A50124C00003, which was awarded to Mapp Biopharmaceutical, Inc. on March 19, 2024. The contract, awarded under Solicitation Number BAA-18-100-SOL-00003, is for the development of medical countermeasures through planned clinical trials and outbreak preparedness. The contract award amount is $38,199,745.00 for CLIN 0001. The contracting office is located in Washington, D.C., and the place of contract performance is the U.S. The closing response date for the solicitation was September 25, 2023.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Post-Award Notice
Contract Number: 75A50124C00003
Awarded: 19 March 2024
Contracting Office ZIP Code: Washington, D.C. 20024
PSC: AJ11
Contracting Office Address: Constitution Center, 400 7th St SW, Washington, D.C. 20204
Subject: Award Notice: Development of Medical Countermeasures through Planned Clinical
Trials and Outbreak Preparedness
Solicitation Number: BAA-18-100-SOL-00003
Closing Response Date: 25 September 2023
Contracting Officer: Richard Hall, richard.hall@hhs.gov
Contract Award Dollar Amount: $38,199,745.00
Line Item Number: CLIN 0001
Contract Award Date: 3/19/2024
Contractor: Mapp Biopharmaceutical, Inc.
Description: Mapp Biopharmaceuticals Inc.’s is to conduct safety and pharmacokinetic studies of
MCMs in countries likely to experience naturally occurring outbreaks, while in parallel preparing each country to collect human clinical data in the event of outbreaks.
Place of Contract Performance: U.S.
Set-aside Status: N/A mailto:richard.hall@hhs.gov
File details come from the government source that posted it. Updated .